Clinical Trial Update: Safety and Efficacy Study of TPX-105 for Correction of Nasojugal Groove [Phase 3]

View source ↗

Summary

Phase 3 trial assessing TPX-105 for correction of tear trough eyelid deformity has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Eye Lid Deformity
• Tear Trough Deformity

Drugs mentioned

• TPX-105

Snippet

Sponsor: Tego Science, Inc. | Conditions: Tear Trough Eyelid Deformity | Phase 3 | Status: COMPLETED